KIT and myocardial infarction: Despite initial reports suggesting that intracoronary infusion of autologous c-KIT+ CPC improved LV systolic function and reduced infarct size in patients with HF after MI (Bolli et al., 2011; Chugh et al., 2012) recently concern has been expressed over the integrity of previously published data (The Lancet Editors, 2014).